Adoption of Liquid Biopsy Tests for NSCLC
Blood-based genomic tests are improving treatment decision and start times.
Read MorePosted by Steve Halasey | Jun 5, 2017 | Cancer, Disease States, Lung Cancer, Molecular Diagnostics, Specimen Collection & Handling |
Blood-based genomic tests are improving treatment decision and start times.
Read MorePosted by Elaine Sanchez Wilson | Apr 26, 2017 | Biochemicals & Chemical Reagents, Cancer, Coagulation Testing, Hematology & Serology, Osteoporosis, Transfusion & Transplantation Tests |
This month’s issue features emerging technologies from such companies as Clinical Genomics, Hamilton Storage, and Symcel.
Read MorePosted by Elaine Sanchez Wilson | Apr 18, 2017 | Cancer |
Facilities will have access to high-throughput biomarker services for identification of novel breath biomarkers in disease diagnostics and precision medicine applications.
Read MorePosted by Elaine Sanchez Wilson | Apr 4, 2017 | Cancer, Molecular Diagnostics |
The dynamic PD-L1 space is providing opportunities to undertake real-time market analysis and ultimately improve our understanding of novel biomarker adoption.
Read MorePosted by Elaine Sanchez Wilson | Feb 28, 2017 | Cancer, Lung Cancer, Molecular Diagnostics |
The partners will also collaborate on the development of new mass spectrometry-based assays in oncology and other clinical areas.
Read More